NIH Weekly Funding Opportunities and Policy Notices
Funding Opportunity PAR-17-150 from the NIH Guide for Grants and Contracts. The purpose of the initiative is to support multidisciplinary innovative exploratory and developmental research to understand the underlying etiologic factors and the mechanisms that result in disparities in chronic liver diseases and cancer in the US. This FOA utilizes the Research Project Grant (R21) mechanism, and is suitable for early phase, pilot, or exploratory/developmental projects. Investigators who are interested in proposing larger scale, later phase projects based upon substantial preliminary data should submit applications to the companion FOA PAR-17-151 of identical scientific scope which uses the NIH (R01) grant mechanism.
Funding Opportunity PAR-17-151 from the NIH Guide for Grants and Contracts. The purpose of the initiative is to support multidisciplinary research to understand the underlying etiologic factors and the mechanisms that result in disparities in chronic liver diseases and cancer in the US.
Notice NOT-AG-17-001 from the NIH Guide for Grants and Contracts
Funding Opportunity PA-17-148 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages Small Business Technology Transfer Research (STTR) grant applications from small business concerns (SBCs) to develop and validate next-generation single cell analysis technologies and tools. The purpose is to foster the commercialization of innovative single cell analysis technologies for their broad use in biomedical research. The novel single-cell analysis technologies will aid in obtaining a fine-grained and dynamic view of heterogeneous cellular states and intercellular interactions, thereby providing new mechanistic insight into biological processes in health and disease. Applications should define the current state of technologies and tools as a benchmark against which the new approach(es) will be measured. The new approach(es) should provide substantially improved performance in sensitivity, selectivity, spatiotemporal resolution, scalability, multiplexing capability, or non-destructive analysis of molecular or functional measures of single cells. A companion FOA to support SBIR Grants is also available see PA-17-147
Funding Opportunity PA-17-147 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) to develop and validate next-generation single cell analysis technologies and tools. The purpose is to foster the commercialization of innovative single cell analysis technologies for their broad use in biomedical research. The novel single-cell analysis technologies will aid in obtaining a fine-grained and dynamic view of heterogeneous cellular states and intercellular interactions, thereby providing new mechanistic insight into biological processes in health and disease. Applications should define the current state of technologies and tools as a benchmark against which the new approach(es) will be measured. The new approach(es) should provide substantially improved performance in sensitivity, selectivity, spatiotemporal resolution, scalability, multiplexing capability, or non-destructive analysis of molecular or functional measures of single cells. A companion FOA to support STTR Grants is also available see PA-17-148
Notice NOT-HL-17-485 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-17-146 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications that develop and test multilevel interventions to improve follow-up to abnormal screening tests for breast, colorectal, cervical and lung cancers. Improving follow-up to abnormal screening tests is dependent on factors at the individual, team, healthcare system or community setting levels. Appropriate applications for this FOA should propose to intervene at one or more levels, and must measure outcomes at three or more levels, while accounting for interactions that occur between levels.
Notice NOT-MH-17-012 from the NIH Guide for Grants and Contracts
Notice NOT-CA-17-018 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-17-145 from the NIH Guide for Grants and Contracts. The purpose of the NINDS Postdoctoral Mentored Career Development Award is to support the ability of outstanding, mentored postdoctoral researchers to develop a potentially impactful research project with a comprehensive career development plan that will enable them to launch an independent research program. Candidates are encouraged to apply for support from this NINDS K01 any time between the second through fourth year of cumulative mentored postdoctoral research experience, and may be supported by this NINDS K01 within the first 6 years of cumulative postdoctoral research experience. Because the completion of a strong, well-planned, thorough career development plan, in addition to development of an impactful research project, is a critical aspect of this K01, applications are strongly encouraged early in the postdoctoral eligibility window. By the end of the proposed K01 award period, the candidate should be poised to begin an independent research career with a well-developed, impactful research project and the expertise required to become a leader in the field.
Notice NOT-AG-17-002 from the NIH Guide for Grants and Contracts
Notice NOT-AR-17-105 from the NIH Guide for Grants and Contracts
Notice NOT-CA-17-024 from the NIH Guide for Grants and Contracts
Notice NOT-AG-17-003 from the NIH Guide for Grants and Contracts
Notice NOT-AI-17-009 from the NIH Guide for Grants and Contracts
Funding Opportunity PA-17-143 from the NIH Guide for Grants and Contracts. The National Cancer Institute (NCI) administers two unique programs focused on supporting technology development research that offer transformative potential for advancing cancer research. The Innovative Molecular Analysis Technologies (IMAT) program supports highly innovative, data-generating platforms and methodologies while the Informatics Technologies for Cancer Research (ITCR) program supports powerful data processing and visualization technologies.
Funding Opportunity PAR-17-142 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications from organizations/institutions in eligible foreign countries that propose research related to infectious diseases that are of interest/importance to that country.
Funding Opportunity RFA-TR-17-006 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites applications for a Clinical and Translational Science Award (CTSA) Program Data to Health Coordination Center (CD2H-CC) that will support the activities of the CTSA Program in using data to translate discoveries to health benefit. The CTSA Program supports high quality translational and clinical research locally, regionally, and nationally, and fosters excellence and innovation in research methods, informatics, training, and career development. The CTSA Program is evolving into an innovative national consortium of academic medical centers that comprises hubs working together to support translational science and improve the research process in order to get more treatments to more patients more quickly. It is expected that the CD2H-CC will 1) support and enhance a collaborative informatics community for the CTSA Program, 2) develop Good Data Practice (GDP) for information stewardship, 3) promote software standards for interoperability, 4) foster collaborative innovation in the area of informatics tools, methods, and processes, 5) stimulate the use of cutting edge biomedical research informatics and data science education for CTSA Program researchers, and 6) evaluate the impact of CD2H-CC activities to enhance health through the use of informatics resources. Through these activities it is expected that the CD2H-CC will discover, develop, demonstrate, and disseminate innovation in informatics tools, standards, methods, and processes and will facilitate collaboration and consortium activities in the area of innovative informatics solutions that will translate to health benefit.
Notice NOT-AI-17-008 from the NIH Guide for Grants and Contracts
Funding Opportunity PA-17-139 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to improve the health outcomes for individuals with deafness and other communication disorders through effectiveness and health services research in the NIDCD mission areas of hearing, balance, smell, taste, voice, speech and language.